Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Most reactions resolved spontaneously without intervention and did not lead to treatment discontinuation
Important Note on BPC-157 Evidence While BPC-157 research is promising, it is important to note that the majority of published studies are preclinical (animal models or in vitro)
Trial-Reported Endpoints by Phase Trial Lancet 2021 Phase 2 Duration 26 weeks Population Overweight/obese, no T2D (n=706) Mean Weight Loss 10.8% at 4.5 mg vs 3.0% placebo Trial Lancet 2023 Phase 2 Duration 32 weeks Population T2D + obesity (n=92) Mean Weight Loss 8.1% cagrilintide alone
This ruling provides a standardised framework, reducing uncertainty
